Phase II Study of Intravenous Rexin-G in Osteosarcoma
Clinical trial NCT00572130 · COMPLETED
Trial details
- NCT number
- NCT00572130
- Sponsor
- Epeius Biotechnologies
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-12-01
- Primary completion
- 2010-07-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.